Limit search to available items
Book Cover
E-book

Title Ex vivo cell therapy / edited Klaus Schindhelm, Robert Nordon
Published San Diego : Academic Press, ©1999

Copies

Description 1 online resource (xix, 356 pages) : illustrations
Contents R.E. Nordon and K. Schindhelm, Introduction. -- L. Robb, A.G. Elefanty, and C.G. Begley, Transcriptional Control of Hematopoieses. -- R. Starr and N.A. Nicola, Cell Signaling by Hemopoietic Growth Factor Receptors. -- P.J. Simmons, D.N. Haylock, and J.-P. Lévesque, Influence of Cytokines and Adhesion Molecules on Hematopoietic Stem Cell Development. -- P.A. Rowlings, Allogeneic Hematopoietic Stem Cell Transplantation. -- U. Hahn and L.B. To, Autologous Stem Cell Transplantation. -- M.R. Vowels, Cord Blood Stem Cell Transplantation. -- S.R. Riddell, E.H. Warren, D. Lewinsohn, C. Yee, and P.D. Greenberg, Reconstitution of Immunity by Adoptive Immunotherapy with T Cells. -- L.Q. Sun, M. Miller, and G. Symonds, Exogenous Gene Transfer into Lymphoid and Hematopoietic Progenitor Cells. -- C. Dowding, T. Leemhuis, A. Jakubowski, and C. Reading, Process Development for Ex Vivo Cell Therapy. -- R.E. Nordon and K. Schindhelm, Cell Separation. -- P.W. Zandstra, C.J. Eaves, and J.M. Piret, Environmental Requirements of Hematopoietic Progenitor Cells in Ex Vivo Expansion Systems. -- R. Mandalam, M. Koller, and A. Smith, Ex Vivo Hematopoietic Cell Expansion for Bone Marrow Transplantation. -- M. Raponi and G. Symonds, Gene Delivery Technology: Nonviral and Viral Vector Systems. -- R.E. Nordon and K. Schindhelm, Summary and Future Directions. -- Index
Sec. 1. Introduction -- Sec. 2. Transcriptional control of hematopoiesis -- Sec. 3. Cell signaling by hematopoietic growth factor receptors -- Sec. 4. Influence of cytokines and adhesion molecules on hematopoietic stem cell development -- Sec. 5. Allogeneic hematopoietic stem cell transplantation -- Sec. 6. Autologous stem cell transplantation -- Sec. 7. Cord blood stem cell transplantation -- Sec. 8. Reconstitution of immunity by adoptive immunotherapy with T cells -- Sec. 9. Exogenous gene transfer into lymphoid and hematopoietic progenitor cells -- Sec. 10. Process development for ex vivo cell therapy -- Sec. 11. Cell separation -- Sec. 12. Environmental requirements of hematopoietic progenitor cells in ex vivo expansion systems -- Sec. 13. Ex vivo hematopoietic cell expansion for bone marrow transplantation -- Sec. 14. Gene delivery technology: nonviral and viral vector systems -- Sec. 15. Summary and future directions
Summary Over the last two decades advances in the understanding of disease at a cellular and molecular level has led to innovative therapies that are based on the administration of cells which have been modified outside of the body. Ex vivo cell therapy is in essence gene therapy delivered by transfer of therapeutic genes to cells in culture, which are then given to the patient to treat fatal infections such as AIDS, or other conditions such as cancer or genetic diseases. These manipulations include the purification and culture of therapeutic cell subtypes, as well as elimination of cells which cause disease (cancer cells or immune cells reacting to the body itself). Gene therapy can be delivered by transfer of therapeutic genes to cells in culture, which are then given to the patient to treat fatal infections such as AIDS, cancer or genetic diseases. For small-scale laboratory methods to become clinically applicable processes, these new therapies require efficient technologies for cell separation, cell production in culture and gene transfer. This book integrates the recent advances in biological and clinical research with developments in cell-based technologies to provide a comprehensive review for clinicians, researchers, biotechnologists and biomedical engineers working in this rapidly developing area. The biotechnology and pharmaceutical industry requires a broad perspective for development of future technologies, and this text will provide then with an excellent overview of this rapidly evolving field. Key Features * Comprehensive review by leading researchers * Hematopoietic stem cell development: transcriptional control, signaling pathways, hematopoietic growth factors and adhesion molecules * Clinical developments: hematopoietic stem cell transplantation, cellular immunotherapy and gene therapy * Enabling technologies: cell separation, bioreactors, and gene transfer regulatory issues
Analysis gentherapie
gene therapy
therapie
therapy
behandeling
treatment
humane ziekten
human diseases
celkweek
cell culture
bloedvorming
haematopoiesis
embryonale stamcellen
embryonic stem cells
transplantatie
transplantation
celbiologie
cellular biology
Pharmacology
Human Pathology
Farmacologie
Humane pathologie
Bibliography Includes bibliographical references and index
Notes Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL
English
Print version record
digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL
Subject Cellular therapy.
Hematopoietic stem cells -- Transplantation
Gene therapy.
Immunotherapy.
Genetic Therapy
Hematopoietic Stem Cell Transplantation
Immunotherapy
Cell- and Tissue-Based Therapy
Immunotherapy
Gene therapy
Cellular therapy
Hematopoietic stem cells -- Transplantation
Histothérapie.
Thérapie génique.
Greffe de cellules souches hématopoïétiques.
Form Electronic book
Author Schindhelm, Klaus
Nordon, Robert
ISBN 9780126249606
0126249601
9780080531335
0080531334